Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New compounds from Novo Nordisk for pain, inflammation, diabetes

Feb. 12, 1999

Astra describes N-type neuronal calcium channel blockers and their use

Feb. 12, 1999

Orally bioavailable tachykinin antagonists from MS&D for emesis, etc.

Feb. 12, 1999

OT-7100, a novel analgesic compound for the treatment of peripheral neuropathic pain

Feb. 11, 1999

Potassium channel modulators claimed for dementia by Bayer

Feb. 11, 1999

RPR and Targacept enter agreement to develop AD and PD treatments

Feb. 11, 1999

Inadvertent overdoses of Cerebyx due to labeling confusion lead to death

Feb. 10, 1999

Effects of NS-105 on cAMP production involve different mGluR groups

Feb. 10, 1999

Effects of NS-7 on Ca2+ channel subtypes and NOS

Feb. 10, 1999

Avanir signs letter of intent with IriSys for ALS drug

Feb. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.